Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice
出版年份 2014 全文链接
标题
Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 16, Issue 12, Pages 1214-1222
出版商
Wiley
发表日期
2014-07-25
DOI
10.1111/dom.12360
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- (pGlu-Gln)-CCK-8[mPEG]: A novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetes
- (2013) Nigel Irwin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effects of short-term chemical ablation of glucagon signalling by peptide-based glucagon receptor antagonists on insulin secretion and glucose homeostasis in mice
- (2013) Zara J. Franklin et al. BIOLOGICAL CHEMISTRY
- Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice
- (2013) N. Irwin et al. DIABETOLOGIA
- desHis1Glu9-glucagon-[mPEG] and desHis1Glu9(Lys30PAL)-glucagon: Long-acting peptide-based PEGylated and acylated glucagon receptor antagonists with potential antidiabetic activity
- (2013) Nigel Irwin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Characterisation of structurally modified analogues of glucagon as potential glucagon receptor antagonists
- (2013) F.P.M. O’Harte et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
- (2013) Sharon A. Sadry et al. Nature Reviews Endocrinology
- Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes
- (2012) N Irwin et al. INTERNATIONAL JOURNAL OF OBESITY
- Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction
- (2012) Sheldon Russell International Journal of Clinical Pharmacy
- Glucagon antagonism as a potential therapeutic target in type 2 diabetes
- (2011) J. I. Bagger et al. DIABETES OBESITY & METABOLISM
- Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
- (2011) F. K. Knop et al. DIABETES OBESITY & METABOLISM
- Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
- (2011) J. Mu et al. DIABETOLOGIA
- Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties
- (2009) Barry D. Kerr et al. BIOCHEMICAL PHARMACOLOGY
- Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible -Cell Hyperplasia and Hyperglucagonemia
- (2009) W. Gu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now